Translational Psychiatry

* Online * Open access *

Translational Psychiatry is a sister journal to the well-established journal in psychiatry, Molecular Psychiatry*, but explores the translational pathway between research in neuroscience and conceptually novel treatments.


The journal recently received an Impact Factor* of 4.730 (22/142 in Psychiatry). The editorial team is led by Julio Licinio, MD, and includes a highly respected international editorial board. Together, the Translational Psychiatry editorial team and NPG look to further define and shape the field of psychiatry and neuroscience.


Visit our author instructions to find out more, or submit to Translational Psychiatry and benefit from open access, global exposure, online submission and reduced publication times. All manuscripts published in Translational Psychiatry are now indexed on eighteen sites, including PubMed and PubMed Central.


* Data is taken from the 2016 Journal Citation Reports, Science Edition (Clarivate Analytics, 2017); Molecular Psychiatry's 2016 Impact Factor is 13.204.

Volume 7,
July 2017

ISSN (online): 2158-3188

2016 Impact Factor 4.730* 22/142 in Psychiatry

Editor:
Julio Licinio, MD

*2016 Journal Citation Reports® Science Edition (Clarivate Analytics, 2017)

NEWS

The authors of a new study published in Translational Psychiatry report that intranasal oxytocin (OT) delivered with a novel nasal device affects social-cognitive behavior. Read the article, the institution's press release, or coverage in Forbes.

Translational Psychiatry is now a member of the Neuroscience Peer Review Consortium (NPRC). The purpose of the NPRC is to decrease the time and effort involved in the peer review process, and reduce the burden placed on reviewers. NPRC member journals agree to transfer manuscript reviews upon the author's request. A flowchart of the transfer process and a list of member journals can be found on the NPRC website.

A study in rodents testing a treatment strategy designed to reverse the acute negative behavioral effects of antidepressants found that antidepressants with longer half-lives have lower rates of suicide-related events (SREs). Read the article, the institution's press release, or coverage in TIME.

Translational Psychiatry authors now have access to NPG's complimentary open access funding service, which provides personal advisement to authors in discovery and application for funding to cover the costs of open access charges. To contact the service, please email apcwaivers@springernature.com.

As an NPG journal, Translational Psychiatry is pleased to offer open access fee waivers to authors based in HINDARI nations. For more information, please see the journal's fee waiver policy.

All manuscripts published in Translational Psychiatry are now indexed on eighteen sites, including PubMed and PubMedCentral!

Extra navigation

23 July 2017

Sign up for e-alerts Web feed Top ten
ADVERTISEMENT